Changes in referral pattern and its effect on outcome in patients with Guillain-Barré syndrome.
The authors assessed the referral pattern and outcome in patients with Guillain-Barré syndrome (n = 266) after the introduction of intravenous immunoglobulin (IVIg). Fewer patients were transferred from small to large hospitals after the introduction of IVIg (p = 0.05). This did not result in a worse outcome in patients treated in small centers. The introduction of IVIg has led to a better use of different levels of health care facilities.
Department of Neurology, Erasmus University Medical Centre Rotterdam, The Netherlands. vankoningsveld@neuro.fgg.eur.nl
R
R
Van Koningsveld
P A
PA
Van Doorn
P I
PI
Schmitz
F G
FG
Van der Meché
D020275:Guillain-Barre Syndrome / Q000188:drug therapy / Q000453:epidemiology*; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D009426:Netherlands / Q000453:epidemiology; D017063:Outcome Assessment, Health Care; D012017:Referral and Consultation / Q000706:statistics & numerical data*; D013997:Time Factors
D016756:Immunoglobulins, Intravenous